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Specialty Update

What’s New in Spine Surgery
Keith H. Bridwell, MD, Paul A. Anderson, MD, Scott D. Boden, MD, Han Jo Kim, MD,
Alexander Vaccaro, MD, PhD, and Jeffrey C. Wang, MD

What’s New in the Treatment of the Cervical Spine?
Microendoscopic Decompression
Posterior cervical microendoscopic decompression is a minimally invasive surgery performed using a tubular retractor
and endoscopic camera or microscope. The purpose is to
reduce muscle trauma compared with conventional approaches. The technique requires extensive training and
there is a steep learning curve. Indications for the procedure are similar to those for traditional posterior cervical
foraminotomy, which include posterolateral disc herniation
and foraminal stenosis. One-year outcomes are similar to
those reported for both standard foraminotomy and anterior
discectomy and fusion. Durotomies occur in 1% to 4% of
cases, greater than the rate for traditional foraminotomy.
Further research is needed to determine the role of minimally
invasive foraminotomy as clinical beneﬁts are not apparent at
this time.
Patient Satisfaction
Patients’ satisfaction with their physicians and care process is
becoming increasingly important and may not be under the
complete control of the practitioner. Abnormal affective disorders are frequently present in patients with spinal conditions
and are associated with overall lower patient satisfaction survey
results. Interestingly, successful patient-reported outcomes
are not correlated with patient satisfaction. Factors such as
smoking, lower-level educational status, and younger age are
associated with lower satisfaction. Speciﬁc provider factors
associated with patient satisfaction are explanation of their
condition, perception of empathy, and recognition of coordinated teamwork.
Specialty Update has been developed in collaboration with the Board of
Specialty Societies (BOS) of the American Academy of Orthopaedic Surgeons.

AO Myelopathy Study
AOSpine North America performed a multi-institutional
observational study of 264 patients with cervical spondylotic
myelopathy. In addition, 366 international patients were enrolled separately. Approximately two-thirds were treated anteriorly, and one-third was treated with a posterior approach.
After adjusting for differences in baseline, no outcome differences were present between the treatment groups; both
groups improved. In North America, the predictors of outcome are age, severity of impairment, smoking status, gait
abnormalities, psychological comorbidities, and baseline
spinal cord cross-sectional area. In the international study,
patients in Asia and Latin America were younger than patients in North America, and more patients in Asia had ossiﬁcation of the posterior longitudinal ligament. The effect of
psychological comorbidities on the prediction of outcomes
was absent outside of North America. Risk factors for complications were older age; comorbidities such as obesity, diabetes, and gastrointestinal disorders; and two-stage or
complex procedures.
Fusion
The Cervical Spine Research Society performed a systematic
literature review to determine the best method that deﬁnes
radiographic fusion success. The best ﬁrst screening method is
to measure the interspinous process tip distance and to compare ﬂexion with extension radiographs. A healed fusion has
a £1-mm difference between the dynamic images. If further
evaluation is needed, then computed tomography (CT) is
recommended.
Complications
Dysphagia is the most common long-term complication after
anterior discectomy and fusion. Application of triamcinolone
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What’s New in Spine Surgery
and, more recently, Depo-Medrol (methylprednisolone) to a
collagen sponge placed in the retropharyngeal space has been
associated with signiﬁcantly less dysphagia. No adverse effect
on fusion or esophageal perforation has been reported, although the studies are underpowered to evaluate this. Other
methods to reduce dysphagia are to have patients perform
preoperative stretching of the esophagus and trachea, to reduce
retraction time, to avoid the use of bone morphogenetic protein (BMP), to use lower-proﬁle and smoother plates, and to
decrease endotracheal cuff pressure. Not surprisingly, postoperative dysphagia is associated with abnormal baseline psychological factors.
The National Surgical Quality Improvement Program
(NSQIP) is a quality improvement program that can be used to
identify speciﬁc complications and potential risk factors. Using
these data, anterior cervical procedures were associated with a
signiﬁcantly lower prevalence of surgical site infection than
posterior procedures. Risk factors for surgical site infection are
a patient body mass index of >35 kg/m2, operative times over
three hours, and chronic corticosteroid use. The use of intrawound vancomycin in case-controlled studies has been shown
to decrease surgical site infection by 63% to 89% compared
with historical controls. However, the study design is inadequate to determine the true effect because of confounding
variables.
Deformity
A method to measure the horizontal translation of the head
and neck is the horizontal offset difference between the sagittal
vertebral axis of C2 and that of C7 (C2-C7 sagittal vertebral
axis). This represents the amount of anterior translation of the
head relative to the thorax. The presence of a large C2-C7
sagittal vertebral axis value results in neck pain and trapezial
spasm, as the trapezius is recruited to attempt to correct deformity. An increased C2-C7 sagittal vertebral axis is associated
with a higher risk of adjacent segment degeneration and increased pain following laminoplasty.
What’s New in Biologics for the Spine?
Recombinant Osteoinductive Proteins
In 2014, there was a continued focus around potential local
and systemic adverse effects associated with recombinant
human bone morphogenetic protein-2 (rhBMP-2) (Infuse;
Medtronic, Memphis, Tennessee), with an emphasis on more
studies that suggest complication rates may not be as high as
originally reported in 2011. Recent North American Spine
Society guidelines have taken a strongly conservative position
on rhBMP-2, but the recent Journal of Neurosurgery: Spine
guidelines support rhBMP-2 as a viable option as a substitute
for iliac crest bone graft alone or when combined with calcium
phosphate extenders or local bone graft. Cost-effectiveness and
cost-utility studies of rhBMP-2 to date have been discordant,
and the result will likely vary on the basis of the speciﬁc clinical
situation (multilevel, impaired host, or posterolateral).

Because serious side effects, such as cancer, are so rare,
authors have resorted to “big data” to shed more light on this issue.
The Yale Open Data Access studies published in 2013, which independently reviewed the pooled clinical trial data, were discordant on the issue of whether rhBMP-2 increased cancer risk. A
Medicare database study suggested that rhBMP-2 was associated
with a slightly lower risk of cancer. A recent study using the
MarketScan Database analyzing 52,000 patients from 2006 to 2010
showed that utilization of BMP-2 was associated with a slightly
lower risk of cancer (odds ratio, 0.92) and a slightly increased risk
of complications (15.8% compared with 14.9%) in multilevel fusions, but decreased rates of infection and wound dehiscence.
A meta-analysis of eight randomized controlled trials
showed that rhBMP-2 resulted in decreased risk of nonunion,
decreased operating room time, decreased bleeding, and decreased risk of reoperation. A decreased risk of reoperation
with rhBMP-2 was also reported in a review of the Kaiser
Permanente database of more than 9000 patients undergoing
fusion. Another analysis using the MarketScan Database reviewed 61,000 cervical spine fusions (2002-2009), including
1677 that used rhBMP-2, and concluded that there was a
substantially higher complication (odds ratio, 1.29) and reoperation rate in the cases that used rhBMP-2. Some surgeons
have reported good results with rhBMP-2 in multilevel cervical
fusions with lower doses than originally reported.
Deformity is an area in which the use of Infuse can yield a
major improvement in fusion success. rhBMP-2 has been reported to be used in 10% to 38% of pediatric spine fusions. The
rate of complications was not increased with use of rhBMP-2
in this patient population. A prospective multicenter trial involving adult spinal deformity reported on the use of rhBMP-2
(2.5 mg/level posteriorly and 50 mg/level interbody). rhBMP-2
was used in larger, more complicated cases, but multivariate
analysis showed no increase in complications.
Other Bone Graft Substitutes
A review of a large national database showed that iliac crest
bone graft was used in only 6% of nearly 14,000 spine fusions,
was 1.5 times more likely to result in blood transfusions, and
was associated with increases in operative time (twenty-two
minutes) and length of stay (0.2 day). Mineralized collagen
matrix (Healos; DePuy Spine, Raynham, Massachusetts) with
bone marrow was shown to perform worse than local bone
graft in posterolateral spine fusion. Silicate-substituted calcium
phosphate (Actifuse; ApaTech, Foxborough, Massachusetts)
was shown to perform much worse than rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion study.
Cellular-based matrices are now estimated to be used in 15% of
spine fusions and are likely safe, but minimal efﬁcacy data are
available for these minimally manipulated tissues.
Biologic Treatments for Disc Degeneration
Progress toward biologic treatments to prevent or to retard
disc degeneration continues. There are continued efforts at
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What’s New in Spine Surgery
injecting mesenchymal stem cells and platelet-rich plasma
into the intervertebral disc of animals and humans. It is
unclear if these cells are intended to participate directly in
disc regeneration or to provide stimulating growth factors.
Most of the studies in the past year have been in vitro proofof-concept studies, which are difﬁcult to translate into the
in vivo setting, making this a rewarding but challenging
area.
What’s New in Spinal Deformity Surgery?
There were 129 podium and 103 poster presentations at the
Scoliosis Research Society (SRS) 49th Annual Meeting &
Course held from September 10 to 13, 2014, in Anchorage,
Alaska.
Adolescent Idiopathic Scoliosis
The National Institutes of Health (NIH) prospective randomized controlled trial, Bracing in Adolescent Idiopathic Scoliosis
Trial (BrAIST), on the efﬁcacy of bracing for adolescent idiopathic scoliosis, demonstrated worse quality of life in patients
whose curves progress to >50° despite brace wear. In addition,
it appears that many patients are at low risk for signiﬁcant
progression with or without brace wear. Although the trial
clearly demonstrated the effectiveness of braces, those who did
not beneﬁt from bracing were skeletally immature and presented with high Cobb angles.
Distal fusion level selection at L3 or L4 was a hot topic for
lumbar curves in patients with adolescent idiopathic scoliosis.
Cohort studies demonstrated similar outcomes regardless of
the lowest instrumented vertebrae at the ﬁve-year follow-up.
Interestingly, there was also no difference in degeneration at the
caudal levels according to the lowest instrumented vertebrae at
a mean follow-up of seven years.
There is increasing attention being focused on reciprocal
changes in the adjacent regional segments of the spine after
fusions for adolescent idiopathic scoliosis. Speciﬁcally, cervical
spine alignment was noted to become more kyphotic with
postoperative thoracic hypokyphosis. The long-term signiﬁcance of this is not known.
The utility of magnetic resonance imaging (MRI) as a
screening tool prior to adolescent idiopathic scoliosis surgery
continues to be questioned. One study of more than 1100
patients demonstrated no difference in the incidence of neural
axis abnormalities in curves of ‡80° or <80°. This indicates
that acquiring MRI preoperatively in the presence of a large
curve alone may not be necessary.
Adult Spinal Deformity
Work from the European Spine Study Group compared the
disease burden of adult spinal deformity to that of other
chronic diseases and concluded that spinal deformity was as
disabling as, if not more disabling than, other chronic diseases.
Continued work from the International Spine Study
Group demonstrated superior outcomes at a minimum two-

year follow-up for patients who underwent operative intervention for adult spinal deformity compared with nonoperative
controls.
The use of BMP in this patient population was investigated again with great interest. BMP was associated with
fewer overall complications and lower rates of revision surgery without any associated increase in cancer risk at the 3.5year follow-up. Even at higher doses (>40 mg), there was no
increased rate of new cancers or recurrence of prior cancers
seen in the cohort. The overall prevalence of cancer was also
not noted to be higher than that reported by the National
Cancer Institute. One study suggested reevaluating the economics of BMP use, stating that their ﬁndings of a 7.5-fold
decrease in reoperation rates when BMP was used may justify
its use.
Neuromuscular Scoliosis
Infection continues to be an important concern in the surgical
treatment of neuromuscular scoliosis. In addition, a study
from the SRS Morbidity and Mortality (M&M) Database revealed these cases to have the highest rates of mortality and
infection.
Early Onset Scoliosis
Preliminary data on vertebral body tethering for the treatment
of early onset scoliosis were reported with a two-year followup. There were eleven patients in the study and a signiﬁcant
correction of their deformity from 44° to 13.5° was noted using
the tether. Two of the eleven patients needed to have a revision
operation to release the tether to avoid overcorrection. It appears that larger studies will be needed to identify those who are
the best candidates for this operation.
Congenital Scoliosis
Data comparing patients with congenital scoliosis who underwent early fusion (at a mean of 5.7 years of age) and late
fusion (at 13.8 years of age) demonstrated that early fusions
had higher rates of revision operations at a mean follow-up of
ﬁfteen years, despite no differences in preoperative curve severity. These ﬁndings question early operative intervention
compared with close observation in younger patients with
congenital scoliosis.
Basic Science
Strong data from a rat model questioned the need for systemic intravenous antibiotic therapy when topical operativesite antibiotics were used. In that study, a total of sixty rats
were given various intravenous antibiotics or a topical local
antibiotic powder application to a surgical site implanted
with a GORE-TEX (W.L. Gore & Associates, Newark, Delaware) graft and methicillin-sensitive Staphylococcus aureus
(MSSA). One week later, the GORE-TEX grafts were retrieved and were cultured; 100% of the rats receiving intravenous antibiotics had positive cultures for MSSA, and 0% of
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the rats receiving the local vancomycin powder had positive
cultures.
What’s New in the Treatment of Spinal Cord Injury?
Multiple clinical trials for the pharmacologic treatment of
spinal cord injury are ongoing in various phases, including
neuroprotective and neuroregenerative strategies. Meanwhile,
enthusiasm for steroid treatment for acute spinal cord injuries
appears to have waned among spine surgeons in recent years.
Acute treatment of spinal cord injury with regard to mean
arterial pressure and time until surgery has also been recently
presented.
In a survey of eighty-four surgeon members of the
Cervical Spine Research Society regarding patients with acute
spinal cord injuries, of the surgeons who reported giving
corticosteroids, 47.4% gave them for complete injuries, 56.4%
gave them for incomplete spinal cord injuries, 46.2% gave
them for complete thoracolumbar injures, and 55.1% gave
them for incomplete injuries. This is a signiﬁcant decrease
compared with 89% of surgeons who had reported giving
corticosteroids in a previous study in 2006. Potential complications were the main reason for not using corticosteroids.
Of those who used corticosteroids, 26% thought that they
improved recovery, 19.2% stated that they were adhering
to institutional protocol, and 25.6% did not think that they
were beneﬁcial, but prescribed on the basis of medicolegal
concerns.
Since completion of the phase-I study, which demonstrated the safety of riluzole for acute spinal cord injury, subject
enrollment for the phase-II/III study began in October 2013.
The study will evaluate superiority of riluzole compared with
placebo when given for acute spinal cord injury within the ﬁrst
twelve hours and continued for thirteen days after injury with a
primary outcome of the American Spinal Injury Association
(ASIA) Motor Score. The study will recruit 351 patients with
acute C4-C8 spinal cord injury.
The Miami Project to Cure Paralysis currently has ﬁve
clinical trials regarding spinal cord injury approved by the
U.S. FDA (Food and Drug Administration). The phase-I
safety trial evaluating autologous human Schwann cells in
subacute injuries began in November 2012 and has been administered in three patients. Patients with traumatic spinal
cord injury between T3 and T11 with complete injuries are
eligible. The ﬁrst two patients received a dose of 5 million cells
and the third patient received a dose of 10 million cells, with
no treatment-related adverse events. This safety trial is actively recruiting ﬁve more participants. The FDA has also
approved testing of one subject for the efﬁcacy of adult mesenchymal stem cells.
In a randomized, prospective, double-blind study, olfactory ensheathing cells with or without Schwann cells were
used to treat chronic complete spinal cord injuries. At the sixmonth follow-up, in the ﬁve patients treated with olfactory
ensheathing cells, Schwann cells, or a combination of the two,

results showed improvements in functional tests and all but
one patient had improvements in electrophysiological tests. A
larger study is likely needed to further evaluate the results of
this small trial.
The study of minocycline in acute spinal cord injury is
currently recruiting participants for a phase-III clinical trial.
The phase-II randomized trial demonstrated safety, as well as a
tendency toward improved outcomes. In the phase-III trial,
intravenous minocycline is given twice daily (800-mg initial
dose, tapered to 400 mg for seven days) within twelve hours of
the injury. The trial began enrolling patients in June 2013 and
is scheduled to be complete in June 2018.
The treatment of mean arterial pressure in patients
with spinal cord injury prior to surgery was recently evaluated and was presented. In that study, mean arterial pressures
were measured throughout initial hospitalization prior to
transfer, throughout the transfer process, and in the ﬁnal
treating hospital. Prior to transfer, the mean arterial pressure
was reported to be below 80 mm Hg in 51% of the recorded
times and below 70 mm Hg in 40% of the times. During
transfer, 31% of readings were below 80 mm Hg and 17%
were below 70 mm Hg, and while waiting for surgery in the
specialist hospital, 49% of readings were below 80 mm Hg
and 20% were below 70 mm Hg. The study also evaluated the
effects of vasopressors on spinal cord perfusion pressures
by placing a lumbar intrathecal catheter caudal to the injury
site at the time of surgery. The authors found an increase in
intrathecal pressure when the patients’ medication was
changed from norepinephrine to dopamine, suggesting that
norepinephrine may lead to improved spinal cord perfusion
(the difference between the mean arterial pressure and intrathecal pressure).
In a study of 949 patients with traumatic spinal cord
injury in the Rick Hansen National Spinal Cord Injury Registry between 2004 and 2013, the time to surgery was evaluated with regard to admitting and postoperative neurological
status. The time until surgery demonstrated no effect on
patients with an ASIA Injury Scale (AIS) A injury at admission. However, patients with AIS B, C, or D injuries increased
their motor score by nearly 7 points when surgery was performed within twenty-four hours, suggesting that early decompression is beneﬁcial for patients with incomplete
injuries.
What’s New in the Treatment of the Lumbar Spine?
There are a number of new research studies that have demonstrated important advances in the treatment of the lumbar
spine.
Intrawound Antibiotics
A recent study looked at osteoblasts taken from ﬁve patients
during spinal fusion surgery and grown in cell culture to
examine the effect of intrawound vancomycin. These cells
were exposed to three different doses of vancomycin at
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concentrations of 3, 6, or 12 mg/cm2. Bone samples from all
ﬁve patients showed emigration of osteoblasts after three to six
days. However, after the addition of vancomycin, emigrated
osteoblasts were only visible in one of the ﬁve samples regardless of concentration. The mean cell viability was 100% in
the group with the lowest dosage of vancomycin, only 97%
in the group with the second-highest dosage of vancomycin,
and 84% in the group with the highest dosage of vancomycin,
which was highly signiﬁcant (p < 0.009). The authors concluded
that the application of vancomycin led to dose-dependent inhibition of cell migration, cell proliferation, and viability, and to
severe morphological changes. This certainly could affect the
union rate after spinal fusion in which vancomycin is applied in
the wound.
Sacroiliac Joint Issues
A recent study looked at the prevalence of sacroiliac joint
degeneration in the asymptomatic population. The authors
looked at 500 patients who underwent abdominal and pelvic
CT scans for reasons other than low back or pelvic girdle pain,
and 373 patients were included in the study. A total of 746
sacroiliac joints were included. The overall prevalence of degeneration in at least one sacroiliac joint was 131 (35%) and the
overall prevalence of signiﬁcant degeneration in at least one
joint was 114 (31%). This prevalence increased with each decade of life from the second decade to the eighth decade. The
authors concluded that degenerative changes in the sacroiliac
joints are prevalent in the asymptomatic population and are
increasingly common with increasing age. The presence of
degenerative changes on imaging studies did not correlate with
symptoms.
Socioeconomics
A recent study looked at the use of cell saver autotransfusion
for short-segment lumbar spinal fusion surgery in 508 patients undergoing lumbar laminectomy and fusion for three
or fewer levels from their prospective spinal outcomes registry. Of these patients, eighty-four (16.5%) had a cell saver
setup for surgery and sixty-ﬁve (77%) of the eighty-four patients received cell saver transfusions. In the same group of
508 patients, ﬁfty-seven patients without cell saver required
allogeneic transfusions. The authors found that cell saver
autologous transfusion was not cost-saving at their institution
for patients undergoing three or fewer levels of spinal laminectomy and fusion.
A group of authors sought to determine if there were any
associations between patient demographic characteristics or
outcomes and loss to follow-up one year after spine surgery.
The authors entered all patients undergoing degenerative
elective spine surgery over a two-year period in a registry. A
total of 1484 patients were included in this study and had
baseline and three-month outcomes available. Of this group,
233 (15.7%) were lost to follow-up at the one-year point. There
were no differences in baseline demographic characteristics or

comorbidities of patients who had follow-up at one year
compared with those who did not, with the exception of age
and employment status. The patients lost to follow-up were
signiﬁcantly younger (p < 0.001) at ﬁfty-one years of age
compared with 57.1 years of age for patients who were not lost
to follow-up, and there was a signiﬁcantly higher proportion
(p = 0.04) of preoperative employment for patients lost to
follow-up (45.9%) compared with patients not lost to followup (41.7%). Preoperative pain, disability, and quality of life
were similar between the two groups (p > 0.05). There was no
difference in ninety-day morbidity or three-month pain, disability, quality of life, and patient satisfaction between the two
groups. In the multivariate analysis model, younger age (p <
0.001) was the only independent predictor of loss to follow-up
at one year. Thus, in a real-world registry of patients undergoing spine surgery, one-year loss to follow-up was about 15%
and the only independent predictor of loss to follow-up in this
degenerative spine population was younger age. Patients lost to
follow-up were not those with worse outcomes or increased
dissatisfaction.
Upcoming Meetings and Events Related to Spine
Surgery
 The EUROSPINE Annual Meeting will be held September 2 through 4, 2015, in Copenhagen, Denmark.
Web site: www.eurospine.org
 The Scoliosis Research Society (SRS) 50th Annual Meeting will be held September 30 through
October 3, 2015, in Minneapolis, Minnesota. Web
site: www.srs.org
 The North American Spine Society (NASS) Annual
Meeting will be held October 14 through 17, 2015, in
Chicago, Illinois. Web site: www.spine.org
 The Cervical Spine Research Society (CSRS) Annual
Meeting will be held December 3 and 4, 2015, in San
Diego, California. Web site: www.csrs.org
 The Federation of Spine Associations will present the
spine program at Specialty Day at the Annual Meeting
of the American Academy of Orthopaedic Surgeons
(AAOS) on March 1, 2016, in Orlando, Florida. Web
site: www.aaos.org
 The International Society for the Advancement of
Spine Surgery (ISASS) 16th Annual Meeting will be
held April 6 through 9, 2016, in Las Vegas, Nevada.
Web site: www.isass.org
 The International Society for the Study of the
Lumbar Spine (ISSLS) Annual Meeting will be held
May 16 through 20, 2016, in Singapore. Web site:
www.issls.org
 The International Meeting on Advanced Spine Techniques (IMAST) 23rd Annual Meeting will be held July
13 through 16, 2016, in Washington, DC. Web site:
www.srs.org
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Evidence-Based Orthopaedics
The editorial staff of The Journal reviewed a large number of
recently published research studies related to the musculoskeletal system that received a higher Level of Evidence grade.
In addition to articles published previously in this journal or
included in the Suggested Readings, twenty-one other articles
with a higher Level of Evidence grade were identiﬁed that were
relevant to spine orthopaedics. A list of those titles is appended
to this review after the standard bibliography. We have provided a brief commentary about each of the articles to help
guide your further reading, in an evidence-based fashion, in
this subspecialty area.
NOTE: The authors thank Dr. Darrel Brodke, Dr. Andrew Hecht, Dr. John Koerner, Dr. K. Daniel Riew,
and Dr. Richard Sasso for peer-reviewing the sections of this manuscript.

UWMF Centennial Building,
1685 Highland Avenue, 6th Floor,
Madison, WI 53705-2281.
E-mail address: anderson@ortho.wisc.edu
Scott D. Boden, MD
Emory University School of Medicine,
59 Executive Park South, Suite 3000,
Atlanta, GA 30329.
E-mail address: Sboden@emory.edu
Han Jo Kim, MD
Hospital for Special Surgery,
535 East 70th Street,
New York, NY 10021.
E-mail address: hanjokimmd@gmail.com
Alexander Vaccaro, MD, PhD
Rothman Institute at Jefferson,
925 Chestnut Street, 5th Floor,
Philadelphia, PA 19107-4216.
E-mail address: alexvaccaro3@aol.com

Keith H. Bridwell, MD
Department of Orthopaedic Surgery,
Washington University School of Medicine,
660 South Euclid Avenue,
Campus Box 8233,
St. Louis, MO 63110.
E-mail address: bridwellk@wudosis.wustl.edu

Jeffrey C. Wang, MD
University of Southern California Spine Center,
1520 San Pablo Street, Suite 2000,
Los Angeles, CA 90033.
E-mail address: Jeffrey.Wang@med.usc.edu

Paul A. Anderson, MD
University of Wisconsin,

Suggested Readings
1. Anderson JT, Haas AR, Percy R, Woods ST, Ahn UM, Ahn NU. Single level lumbar
fusion for degenerative disc disease is associated with worse outcomes compared
to fusion for spondylolisthesis in a Workers’ Compensation setting. Spine (Phila Pa
1976). 2014 Dec 9. [Epub ahead of print].
2. Casha S, Zygun D, McGowan MD, Bains I, Yong VW, Hurlbert RJ. Results of a
phase II placebo-controlled randomized trial of minocycline in acute spinal cord
injury. Brain. 2012 Apr;135(Pt 4):1224-36.
3. Chen L, Huang H, Xi H, Zhang F, Liu Y, Chen D, Xiao J. A prospective randomized
double-blind clinical trial using a combination of olfactory ensheathing cells and
Schwann cells for the treatment of chronic complete spinal cord injuries. Cell
Transplant. 2014;23(Suppl 1):35-44. Epub 2014 Oct 20.
4. Chiang HY, Herwaldt LA, Blevins AE, Cho E, Schweizer ML. Effectiveness of local
vancomycin powder to decrease surgical site infections: a meta-analysis. Spine J.
2014 Mar 1;14(3):397-407. Epub 2013 Oct 30.
5. Coe JD, Vaccaro AR, Dailey AT, Sasso RC, Ludwig SC, Harrop JS, Dettori JR,
Shaffrey CI, Emery SE, Fehlings MG. Letter to the editor: lateral mass screw ﬁxation
in the cervical spine. J Neurosurg: Spine. 2014 May;20(5):592-6.
6. De la Garza-Ramos R, Bydon M, Abt NB, Sciubba DM, Wolinsky JP, Bydon A,
Gokaslan ZL, Rabin B, Witham TF. The impact of obesity on short- and long-term
outcomes after lumbar fusion. Spine (Phila Pa 1976). 2015 Jan 1;40(1):
56-61.
7. Fehlings MG, Barry S, Kopjar B, Yoon ST, Arnold P, Massicotte EM, Vaccaro A,
Brodke DS, Shaffrey C, Smith JS, Woodard E, Banco RJ, Chapman J, Janssen M,
Bono C, Sasso R, Dekutoski M, Gokaslan ZL. Anterior versus posterior surgical
approaches to treat cervical spondylotic myelopathy: outcomes of the prospective
multicenter AOSpine North America CSM study in 264 patients. Spine (Phila Pa
1976). 2013 Dec 15;38(26):2247-52.
8. Fehlings MG, Theodore N, Harrop J, Maurais G, Kuntz C, Shaffrey CI, Kwon BK,
Chapman J, Yee A, Tighe A, McKerracher L. A phase I/IIa clinical trial of a recombinant rho protein antagonist in acute spinal cord injury. J Neurotrauma. 2011
May;28(5):787-96.
9. Guppy KH, Paxton EW, Harris J, Alvarez J, Bernbeck J. Does bone morphogenetic
protein change the operative nonunion rates in spine fusions? Spine (Phila Pa
1976). 2014 Oct 15;39(22):1831-9.
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Evidence-Based Articles

Hurlbert RJ, Alexander D, Bailey S, Mahood J, Abraham E, McBroom R,
Jodoin A, Fisher C. rhBMP-2 for posterolateral instrumented lumbar fusion:
a multicenter prospective randomized controlled trial. Spine (Phila Pa 1976).
2013 Dec 1;38(25):2139-48.
The authors demonstrated that the use of rhBMP-2 for instrumented
posterolateral lumbar surgery signiﬁcantly improved the chances of radiographic fusion compared with the use of autograft.

Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ. Interventions
available over the counter and advice for acute low back pain: systematic review
and meta-analysis. J Pain. 2014 Jan;15(1):2-15. Epub 2013 Oct 14.
There is limited evidence that nonsteroidal anti-inﬂammatory drugs,
heat wrap, and rubefacients provide immediate pain relief for acute back pain
and that bed rest and advice are both ineffective.
Goz V, McCarthy I, Weinreb JH, Dallas K, Bendo JA, Lafage V, Errico TJ.
Venous thromboembolic events after spinal fusion: which patients are at high
risk? J Bone Joint Surg Am. 2014 Jun 4;96(11):936-42. [Epub ahead of print].
Using the National Inpatient Sample database, the authors determined
the prevalence and risk factors for venous thromboembolism in patients undergoing spine fusion. From 2001 to 2010, more than 700,000 patients were
included, having an overall incidence of venous thromboembolism of 0.50%,
of which 0.29% were deep venous thromboses and 0.24% were pulmonary
emboli. Risk factors were typical of known factors including a hypercoagulability
state, certain medical comorbidities, older age, and male sex.
Hart R, Komzák M, Okál F, Náhlı́k D, Jajtner P, Puskeiler M. Allograft alone
versus allograft with bone marrow concentrate for the healing of the instrumented posterolateral lumbar fusion. Spine J. 2014 Jul 1;14(7):1318-24.
Epub 2013 Dec 20.
This study was a prospective, randomized, controlled, blinded comparison of allograft alone with allograft plus bone marrow concentrate to accomplish spine fusion in the adult population with spondylolisthesis. The
group that had autologous bone marrow concentrate had a higher percentage of
patients with apparent fusion than the group that did not. However, both
groups had very poor union rates. Apparently allograft by itself is a terrible
option and allograft with bone marrow concentrate is a better, but still not very
good, option.

Jee H, Lee JH, Park KD, Ahn J, Park Y. Ultrasound-guided versus ﬂuoroscopyguided sacroiliac joint intra-articular injections in the noninﬂammatory sacroiliac joint dysfunction: a prospective, randomized, single-blinded study.
Arch Phys Med Rehabil. 2014 Feb;95(2):330-7. Epub 2013 Oct 9.
This was a prospective randomized controlled trial comparing the
short-term effects and safety of ultrasound-guided sacroiliac joint injections
with ﬂuoroscopy-guided sacroiliac joint injections in patients with noninﬂammatory sacroiliac joint issues. There were 120 patients enrolled and results
were compared at two and twelve weeks following the procedure. Of the ﬁftyﬁve ultrasound-guided injections, forty-eight (87.3%) were successful and
seven (12.7%) missed. For the ﬂuoroscopy-guided injections, 98.2% were accurate, and three cases of intravascular injections occurred. The function and
pain relief were similar in both groups, making the ultrasound-guided approach just as effective as the ﬂuoroscopy-guided approach, but the accuracy
rate was lower.

Holden J, Davidson M, O’Halloran PD. Health coaching for low back pain:
a systematic review of the literature. Int J Clin Pract. 2014 Aug;68(8):950-62.
Epub 2014 Apr 22.
This systematic review concluded that there is no available literature to
provide good evidence on the efﬁcacy of health coaching on the treatment of
subacute back pain. All included studies documented change; however, the
content of counseling programs varied among studies and measures of treatment ﬁdelity were not consistent, precluding deﬁnitive conclusions. The lack of
uniform protocols and clear interventions makes studying this clinical issue
difﬁcult.

Khurana G, Jindal P, Sharma JP, Bansal KK. Postoperative pain and longterm functional outcome after administration of gabapentin and pregabalin in
patients undergoing spinal surgery. Spine (Phila Pa 1976). 2014 Mar 15;39(6):
E363-8.
This was a prospective, double-blind, randomized controlled trial to
evaluate and to compare the analgesic efﬁcacy, adverse effects, and clinical
utility of gabapentin and pregabalin in postoperative pain treatment, long-term
functional outcome, and quality of life in a total of ninety patients undergoing
lumbar discectomy surgery. One hour before surgery and every eight hours for
seven days, group A received 300 mg of gabapentin, group B received 75 mg of
pregabalin, and group C received one placebo dose. The patients receiving
pregabalin consistently showed reduced static and dynamic pain intensity and
required less rescue drugs throughout the postoperative period. The Prolo score
and Oswestry Disability Index score were signiﬁcantly different (p < 0.05)
between group B and group C at all time points. Preoperative pregabalin was
associated with less pain intensity and improved functional outcomes three
months after lumbar discectomy. This was followed by gabapentin and then
placebo.

Huang Z, Wan S, Ning L, Han S. Is unilateral kyphoplasty as effective and safe
as bilateral kyphoplasties for osteoporotic vertebral compression fractures?
A meta-analysis. Clin Orthop Relat Res. 2014 Sep;472(9):2833-42. Epub 2014
Jun 26.
This meta-analysis, which included ﬁve studies and 253 patients,
evaluated the superiority of unilateral compared with bilateral percutaneous
kyphoplasty for the treatment of osteoporotic vertebral compression fractures.
The authors evaluated the visual analog scale (VAS) for back pain, Oswestry
Disability Index, complication rates, kyphosis angle, anterior vertebral body
height restoration, and operative times. There were no differences between
treatment methods except for a shorter operative time with unilateral approaches. The sample sizes of all included studies were small. The authors
suggested that unilateral approaches be used because of shorter operative time
and lower cost, but high-quality studies are needed to conﬁrm these ﬁndings.

Kim KT, Cho DC, Sung JK, Kim YB, Kang H, Song KS, Choi GJ. Intraoperative systemic infusion of lidocaine reduces postoperative pain after
lumbar surgery: a double-blinded, randomized, placebo-controlled clinical
trial. Spine J. 2014 Aug 1;14(8):1559-66. Epub 2013 Nov 8.
This prospective, randomized, double-blinded trial evaluated the
effects of intraoperative systemic lidocaine infusion on postoperative pain
compared with a normal saline control infusion. Fifty-one patients underwent lumbar microdiscectomy by the same surgeon. The primary outcome
measure was VAS pain at four hours after surgery. The VAS scores were
signiﬁcantly lower in the treatment group at all time points except at fortyeight hours after surgery. There were no adverse events associated with lidocaine infusion. The frequency of pushing the button of patient-controlled
analgesia systems and total fentanyl administered were signiﬁcantly lower in
the lidocaine treatment group compared with controls. The length of hospital
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stay was also signiﬁcantly shorter in the lidocaine group (six days) compared
with the control group (seven days).
Manchikanti L, Benyamin RM, Falco FJE, Kaye AD, Hirsch JA. Do epidural
injections provide short- and long-term relief for lumbar disc herniation? A
systematic review. Clin Orthop Relat Res. 2014 Feb 11. [Epub ahead of print].
This systematic review determined the efﬁcacy in terms of pain relief
and functional improvement of caudal, interlaminar, and interforaminal
epidural injections using ﬂuoroscopy for the treatment of disc herniations.
Sixty-six studies were assessed using Cochrane review criteria, which left
twenty-three randomized controlled trials for analysis. Pain relief was deﬁned as at least 50% improvement or 3-point improvement in pain scores in
at least 50% of patients. Functional improvement was deﬁned as 50% reduction in disability or 30% reduction in disability scores. All epidural approaches had strong evidence for short-term relief (less than six months) and
moderate evidence for long-term relief (six months or more). The heterogeneity of the trials did not allow pooled quantitative analysis of the studies,
and future studies need to be appropriately designed with validated outcome
parameters.
McGregor AH, Probyn K, Cro S, Doré CJ, Burton AK, Balagué F, Pincus T,
Fairbank J. Rehabilitation following surgery for lumbar spinal stenosis. A
Cochrane review. Spine (Phila Pa 1976). 2014 Jun 1;39(13):1044-54.
The authors found moderate-quality evidence indicating that postoperative active rehabilitation after decompression surgery for lumbar spinal
stenosis is more cost-effective than the usual care.
Nakashima H, Kato F, Yukawa Y, Imagama S, Ito K, Machino M, Ishiguro N.
Comparative effectiveness of open-door laminoplasty versus French-door
laminoplasty in cervical compressive myelopathy. Spine (Phila Pa 1976). 2014
Apr 15;39(8):642-7.
In this prospective, randomized study, open-door laminoplasty was
compared with French-door laminoplasty for cervical myelopathy. Ninetytwo patients were studied. The two techniques demonstrated identical
neurological recovery and perioperative complications. However, the patients who had undergone laminoplasty with the open-door technique had
more cervical kyphosis and less cervical range of motion postoperatively
than patients who had undergone laminoplasty with the French-door
technique.
Oosterhuis T, Costa LO, Maher CG, de Vet HC, van Tulder MW, Ostelo RW.
Rehabilitation after lumbar disc surgery. Cochrane Database Syst Rev. 2014;3:
CD003007. Epub 2014 Mar 14.
The purpose of this study was to determine whether active rehabilitation after lumbar disc surgery is more effective than no treatment and
which type of active rehabilitation is most effective. In this update to a
prior review published in 2002, eight new studies were identiﬁed, which
included twenty-two new trials with 2503 participants. All patients had
undergone a discectomy (standard, microdiscectomy, or laminectomy and
discectomy) and the overall mean patient age was 41.4 years. No signiﬁcant
differences were seen between supervised and home exercise programs
with regard to pain relief, disability, or global perceived effect. The
quality of the evidence was low to very low, but exercise programs starting
four to six weeks post-surgery seem to lead to a quicker decrease in disability and pain compared with no treatment. High-intensity programs
seem to lead to a slightly faster decrease in pain and disability compared
with low-intensity programs.
Patel S, Friede T, Froud R, Evans DW, Underwood M. Systematic review of
randomized controlled trials of clinical prediction rules for physical therapy in
low back pain. Spine (Phila Pa 1976). 2013 Apr 20;38(9):762-9.
The purpose of this study was to evaluate randomized controlled
trials validating the effects of a clinical prediction rule for physical therapy
for nonspeciﬁc low back pain. Clinical prediction rules can be beneﬁcial in
determining which patients will respond best to speciﬁc interventions.

Three studies were included in the systematic review. One study found a
greater improvement in the Oswestry Disability Index for patients who
were matched into the most appropriate treatment for the subgroup.
Another study found the greatest treatment beneﬁt in patients who met
certain criteria prior to treatment. The third study found no interaction
between treatment groups and the prediction rule. Overall, the authors
found that the evidence validating clinical prediction rules for low back
pain is weak.
Poetscher AW, Gentil AF, Lenza M, Ferretti M. Radiofrequency denervation
for facet joint low back pain: a systematic review. Spine (Phila Pa 1976). 2014
Jun 15;39(14):E842-9.
This was a systematic review and meta-analysis of randomized controlled trials to assess the treatment effects (both the beneﬁts and harms) of
radiofrequency denervation for patients with facet joint-related chronic low
back pain. Fifteen studies were selected, and, of these, nine were appropriate,
but the evidence was rated as low to moderate. The evidence shows that radiofrequency denervation of facet joints is more effective than placebo in
functional improvement and pain control and possibly more effective than
steroid injections in pain control. There was not sufﬁcient reporting of adverse
effects and complications to allow for comparisons and there was no evidence
for cost-effectiveness.
Roh GU, Yang SY, Shim JK, Kwak YL. Efﬁcacy of palonosetron versus
ramosetron on preventing opioid-based analgesia-related nausea and vomiting
after lumbar spinal surgery: a prospective, randomized, and double-blind trial.
Spine (Phila Pa 1976). 2014 Apr 20;39(9):E543-9.
This was a prospective, randomized, double-blinded study to compare the beneﬁts of ramosetron to palonosetron in controlling postoperative
opioid-induced nausea and vomiting in patients after lumbar spinal surgery.
Ramosetron was superior to palonosetron in terms of reducing the prevalence
and severity of nausea associated with intravenous opioids after lumbar spine
surgery.
Song KS, Piyaskulkaew C, Chuntarapas T, Buchowski JM, Kim HJ, Park MS,
Kang H, Riew KD. Dynamic radiographic criteria for detecting pseudarthrosis
following anterior cervical arthrodesis. J Bone Joint Surg Am. 2014 Apr 2;96
(7):557-63.
This was a retrospective review of cervical fusion assessment using
dynamic radiographs with CT conﬁrmation. This study concluded that with
a magniﬁcation of 150% and a good pair of ﬂexion and extension radiographs (deﬁned as one with >4 mm of interspinous process motion), a
pseudarthrosis was noted with >1 mm of motion between fused interspinous processes with 96.1% speciﬁcity and a positive predictive value of
96.9%.
Vaccaro A, Beutler W, Peppelman W, Marzluff JM, Highsmith J, Mugglin A,
DeMuth G, Gudipally M, Baker KJ. Clinical outcomes with selectively constrained SECURE-C cervical disc arthroplasty: two-year results from a prospective, randomized, controlled, multicenter investigational device exemption
study. Spine (Phila Pa 1976). 2013 Dec 15;38(26):2227-39.
The authors showed that SECURE-C was statistically superior in terms
of overall success, index-level subsequent surgical procedures, and patient
satisfaction compared with anterior cervical discectomy and fusion.
Verma K, Errico T, Diefenbach C, Hoelscher C, Peters A, Dryer J, Huncke T,
Boenigk K, Lonner BS. The relative efﬁcacy of antiﬁbrinolytics in adolescent
idiopathic scoliosis: a prospective randomized trial. J Bone Joint Surg Am. 2014
May 21;96(10):e80.
This randomized controlled trial compared the efﬁcacy of intravenous
tranexamic acid, epsilon-aminocaproic acid, and placebo to reduce bleeding in
125 patients with adolescent idiopathic scoliosis undergoing posterior fusion.
They found less intraoperative and postoperative blood loss and higher hematocrit levels than placebo with use of the antiﬁbrinolytics when arterial
blood pressure was <75 mm Hg during exposure. Although a positive trial, the
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study showed only a minimal clinical effect because transfusion requirements
were no different between groups.

but the difference was not signiﬁcant. However, any conclusions are limited by
poor follow-up and the signiﬁcant heterogeneity of included studies.

Verma K, Gandhi SD, Maltenfort M, Albert TJ, Hilibrand AS, Vaccaro AR,
Radcliff KE. Rate of adjacent segment disease in cervical disc arthroplasty
versus single-level fusion: meta-analysis of prospective studies. Spine (Phila Pa
1976). 2013 Dec 15;38(26):2253-7.
The authors performed a meta-analysis of six randomized clinical trials
including 1586 patients comparing the rate of adjacent segment reoperation
between cervical arthroplasty and fusion after discectomy. They found that the
reoperation rate was higher following fusion (6.9%) than arthroplasty (5.1%),

Villard J, Ryang YM, Demetriades AK, Reinke A, Behr M, Preuss A, Meyer B,
Ringel F. Radiation exposure to the surgeon and the patient during posterior
lumbar spinal instrumentation: a prospective randomized comparison of
navigated versus non-navigated freehand techniques. Spine (Phila Pa 1976).
2014 Jun 1;39(13):1004-9.
The authors found that radiation exposure to the surgeon during
pedicle screw insertion with the freehand technique is up to ten times greater
than with the use of navigation.

